Azetukalner
XPF-010-D303
Phase 3 small_molecule active
Quick answer
Azetukalner for Major Depressive Disorder is a Phase 3 program (small_molecule) at Xenon Pharmaceuticals with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Xenon Pharmaceuticals
- Indication
- Major Depressive Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active